AI Summary
We reviewed 19 live results for xeljanz (tofacitinib) and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Pharmaceuticals and Rheumatology.
Comparison Table
Recommended
XELJANZ
Source: Pfizer (Thailand) Ltd.
Description
XELJANZ is a prescription medicine containing tofacitinib, a Janus kinase (JAK) inhibitor used to treat adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It is available as 5 mg film-coated tablets and is registered with the Thai FDA.
Best for
rheumatoid arthritis patients, psoriatic arthritis, hospital prescriptions and official brand preference
View Details
Rating
Xeljanz (Tofacitinib)
Source: Pfizer Thailand
Description
Xeljanz is the innovator brand of tofacitinib registered in Thailand. It is available in 5 mg film-coated tablets and 11 mg extended-release (XR) formats for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis at major hospitals.
Best for
patients in Thailand, innovator drug preference, insured medical treatments and hospital-based pharmacy users
View Details
Rating
Xeljanz (tofacitinib)
Source: Pfizer
Description
Xeljanz is a prescription Janus kinase (JAK) inhibitor used to treat adults with moderately to severely active rheumatoid arthritis (RA), psoriatic arthritis, and ulcerative colitis. As a brand-name pharmaceutical, it is available in 5mg immediate-release and 11mg extended-release (XR) tablet formulations designed to reduce inflammation and manage symptoms of autoimmune diseases.
Best for
rheumatoid arthritis patients, prescribed JAK inhibitors, autoimmune disease management and ulcerative colitis treatment
View Details
Rating
| Compare | XELJANZ | Xeljanz (Tofacitinib) | Xeljanz (tofacitinib) |
|---|---|---|---|
| Source | Pfizer (Thailand) Ltd. | Pfizer Thailand | Pfizer |
| Description | XELJANZ is a prescription medicine containing tofacitinib, a Janus kinase (JAK) inhibitor used to treat adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It is available as 5 mg film-coated tablets and is registered with the Thai FDA. | Xeljanz is the innovator brand of tofacitinib registered in Thailand. It is available in 5 mg film-coated tablets and 11 mg extended-release (XR) formats for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis at major hospitals. | Xeljanz is a prescription Janus kinase (JAK) inhibitor used to treat adults with moderately to severely active rheumatoid arthritis (RA), psoriatic arthritis, and ulcerative colitis. As a brand-name pharmaceutical, it is available in 5mg immediate-release and 11mg extended-release (XR) tablet formulations designed to reduce inflammation and manage symptoms of autoimmune diseases. |
| Best for | rheumatoid arthritis patients, psoriatic arthritis, hospital prescriptions and official brand preference | patients in Thailand, innovator drug preference, insured medical treatments and hospital-based pharmacy users | rheumatoid arthritis patients, prescribed JAK inhibitors, autoimmune disease management and ulcerative colitis treatment |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
AI Recommendation
If you want the most balanced option to start with, I recommend:
"XELJANZ from Pfizer (Thailand) Ltd.."
I picked this because This is the original manufacturer's brand, officially registered with the Thai FDA and widely available in major hospitals for guaranteed quality.
Share this search
Related Finds